Novartis (NVS) plans to file for Japanese and EU approval of QVA149 - a therapy that combines...

|About: Novartis AG (NVS)|By:, SA News Editor

Novartis (NVS) plans to file for Japanese and EU approval of QVA149 - a therapy that combines two of the company's other drugs and is used to treat smoker's cough - later this year after it met expectations in final trials. Yesterday, the FDA authorized a new dosage of Novartis' cancer drug Afinitor so it can be used to treat children with a rare brain tumor. (PR)